FDA Inspection 1192813 — David G. Evans, O.D.
The FDA completed an inspection of David G. Evans, O.D. on Dec 9, 2022 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Memphis, TN (United States)
Additional Details
Clinical Investigator (CI)